Amoytop Biotech Partnership
Reached a general sub-licensing agreement with Amoytop Biotech in China to initiate preclinical drug development in January 2013.
University of Southern California Partnership
Completed core technology licensing for HSP90 from University of Southern California in May 2012.
Department of Defense Grant
$100,000 SBIR grant from US Army in December 2011 to work on wound healing.